VVUS: VIVUS INC. (NASDAQ) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: RT who wrote (5175)	2/1/1998 10:30:00 AM
From: Gene Voss	Read Replies (1) of 23519

RT:This is part of the patent dispute between Vivus and HVSF.I don't have the complete # at hand but a review of HVSF's recent patent will refer to it.Have your local patent atty review the significance of the claims.The claims are always open to challenge which is why HVSF and Vivus are litigating.If you really want to know who has protection and if any exposure exists ask a professional. My opinion is that the HVSF transurethral technique does infringe but as I said earlier spend the $100 or so and find out don't take my opinion for anything.This is good advice for anyone investing in technological issues when intellectual property and company claims are so important. GV

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next